BIOMAT Database Logo BIOMAT Database Logo

Effects of U-46619 on pulmonary hemodynamics before and after administration of BM-573, a novel thromboxane A2 inhibitor. 2003

B Lambermont, and P Kolh, and J-M Dogné, and A Ghuysen, and V Tchana-Sato, and P Morimont, and P Benoit, and P Gérard, and B Masereel, and R Limet, and V D'Orio
Hemodynamics Research Laboratory (HemoLiege), University of Liège, Belgium. b.lambermont@chu.ulg.ac.be

We studied the effects on pulmonary hemodynamics of U-46619, a thromboxane A2 (TXA2) agonist, before and after administration of a novel TXA2 receptor antagonist and synthase inhibitor (BM-573). Six anesthetized pigs (Ago group) received 6 consecutive injections of U-46619 at 30-min interval and were compared with six anesthetized pigs (Anta group) which received an increasing dosage regimen of BM-573 10 min before each U-46619 injection. Consecutive changes in pulmonary hemodynamics, including characteristic resistance, vascular compliance, and peripheral vascular resistance, were continuously assessed during the experimental protocol using a four-element Windkessel model. At 2 mg/kg, BM-573 completely blocked pulmonary hypertensive effects of U-46619 but pulmonary vascular compliance still decreased. This residual effect can probably be explained by a persistent increase in the tonus of the pulmonary vascular wall smooth muscles sufficient to decrease vascular compliance but not vessel lumen diameter. Such molecule could be a promising therapeutic approach in TXA2 mediated pulmonary hypertension as it is the case in pulmonary embolism, hyperacute lung rejection and endotoxinic shock.

UI MeSH Term Description Entries
D008297 Male Males
D008955 Models, Cardiovascular Theoretical representations that simulate the behavior or activity of the cardiovascular system, processes, or phenomena; includes the use of mathematical equations, computers and other electronic equipment. Cardiovascular Model,Cardiovascular Models,Model, Cardiovascular
D011651 Pulmonary Artery The short wide vessel arising from the conus arteriosus of the right ventricle and conveying unaerated blood to the lungs. Arteries, Pulmonary,Artery, Pulmonary,Pulmonary Arteries
D011652 Pulmonary Circulation The circulation of the BLOOD through the LUNGS. Pulmonary Blood Flow,Respiratory Circulation,Circulation, Pulmonary,Circulation, Respiratory,Blood Flow, Pulmonary,Flow, Pulmonary Blood,Pulmonary Blood Flows
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006339 Heart Rate The number of times the HEART VENTRICLES contract per unit of time, usually per minute. Cardiac Rate,Chronotropism, Cardiac,Heart Rate Control,Heartbeat,Pulse Rate,Cardiac Chronotropy,Cardiac Chronotropism,Cardiac Rates,Chronotropy, Cardiac,Control, Heart Rate,Heart Rates,Heartbeats,Pulse Rates,Rate Control, Heart,Rate, Cardiac,Rate, Heart,Rate, Pulse
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013453 Sulfonylurea Compounds A class of compounds in which a sulfone functional group is attached to UREA. Compounds, Sulfonylurea

Related Publications

B Lambermont, and P Kolh, and J-M Dogné, and A Ghuysen, and V Tchana-Sato, and P Morimont, and P Benoit, and P Gérard, and B Masereel, and R Limet, and V D'Orio
U-46619, a selective thromboxane A2-like agonist? [proceedings].
January 1980, British journal of pharmacology,
B Lambermont, and P Kolh, and J-M Dogné, and A Ghuysen, and V Tchana-Sato, and P Morimont, and P Benoit, and P Gérard, and B Masereel, and R Limet, and V D'Orio
Thromboxane A2 analogue (U-46619) stimulates vascular PGI2 synthesis.
January 1985, European journal of pharmacology,
B Lambermont, and P Kolh, and J-M Dogné, and A Ghuysen, and V Tchana-Sato, and P Morimont, and P Benoit, and P Gérard, and B Masereel, and R Limet, and V D'Orio
Protective effects of the thromboxane receptor antagonists BM 13.177 and BM 13.505 against U 46619-induced sudden death in rats.
January 1988, Pharmacology,
B Lambermont, and P Kolh, and J-M Dogné, and A Ghuysen, and V Tchana-Sato, and P Morimont, and P Benoit, and P Gérard, and B Masereel, and R Limet, and V D'Orio
Thromboxane A2 mimetic U-46619 induces systemic and pulmonary hypertension and delayed tachypnea in the goat.
September 1994, Journal of applied physiology (Bethesda, Md. : 1985),
B Lambermont, and P Kolh, and J-M Dogné, and A Ghuysen, and V Tchana-Sato, and P Morimont, and P Benoit, and P Gérard, and B Masereel, and R Limet, and V D'Orio
Activity of a novel dual thromboxane A(2)receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth muscles.
August 2001, Prostaglandins, leukotrienes, and essential fatty acids,
B Lambermont, and P Kolh, and J-M Dogné, and A Ghuysen, and V Tchana-Sato, and P Morimont, and P Benoit, and P Gérard, and B Masereel, and R Limet, and V D'Orio
Drug induced inhibition of the cardiac effects of U 46619 as a thromboxane A2-like agonist.
January 1984, Biomedica biochimica acta,
B Lambermont, and P Kolh, and J-M Dogné, and A Ghuysen, and V Tchana-Sato, and P Morimont, and P Benoit, and P Gérard, and B Masereel, and R Limet, and V D'Orio
In vitro effects of a thromboxane A2-analogue U-46619 and noradrenaline on contractions of the human thoracic duct.
September 1991, Lymphology,
B Lambermont, and P Kolh, and J-M Dogné, and A Ghuysen, and V Tchana-Sato, and P Morimont, and P Benoit, and P Gérard, and B Masereel, and R Limet, and V D'Orio
Effect of the thromboxane A2 mimetic U 46619 on pial arterioles of rabbits and rats.
January 1987, Stroke,
B Lambermont, and P Kolh, and J-M Dogné, and A Ghuysen, and V Tchana-Sato, and P Morimont, and P Benoit, and P Gérard, and B Masereel, and R Limet, and V D'Orio
Synthesis and inhibitory activity of isoindolinone derivatives on thromboxane A2 analog (U-46619)-induced vasocontraction.
July 1990, Chemical & pharmaceutical bulletin,
B Lambermont, and P Kolh, and J-M Dogné, and A Ghuysen, and V Tchana-Sato, and P Morimont, and P Benoit, and P Gérard, and B Masereel, and R Limet, and V D'Orio
Thromboxane A2 analogue, U-46619, potentiates calcium-activated force in human umbilical artery.
June 1993, The American journal of physiology,
Copied contents to your clipboard!